Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/01/2873602/0/en/Journey-Medical-Corporation-Appoints-Joseph-Benesch-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/04/25/2869654/0/en/Journey-Medical-Corporation-to-Present-at-the-Planet-MicroCap-Showcase-Vegas-2024.html
https://www.globenewswire.com/news-release/2024/03/21/2850606/0/en/Journey-Medical-Corporation-Reports-Full-Year-2023-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.globenewswire.com/news-release/2024/03/18/2847801/0/en/Journey-Medical-Corporation-Announces-U-S-FDA-Acceptance-of-New-Drug-Application-for-DFD-29-for-the-Treatment-of-Rosacea.html
https://www.globenewswire.com/news-release/2024/03/18/2847801/0/en/Journey-Medical-Corporation-Announces-U-S-FDA-Acceptance-of-New-Drug-Application-for-DFD-29-for-the-Treatment-of-Rosacea.html
https://www.globenewswire.com//news-release/2024/03/15/2847037/0/en/Journey-Medical-Corporation-to-Announce-Year-End-2023-Financial-Results-on-March-21-2024.html
https://www.globenewswire.com//news-release/2024/03/13/2845438/0/en/Journey-Medical-Corporation-to-Participate-in-the-36th-Annual-ROTH-Conference.html
https://www.globenewswire.com//news-release/2024/03/11/2843786/0/en/Journey-Medical-Corporation-Announces-Presentation-of-Data-from-Phase-1-Clinical-Trial-Assessing-the-Impact-of-DFD-29-Minocycline-Hydrochloride-Modified-Release-Capsules-40-mg-on-M.html
https://www.globenewswire.com//news-release/2024/01/05/2804636/0/en/Journey-Medical-Corporation-Submits-New-Drug-Application-to-FDA-for-DFD-29-to-Treat-Rosacea.html
https://www.globenewswire.com//news-release/2024/01/02/2802935/0/en/Journey-Medical-Corporation-Secures-Credit-Facility-with-SWK-Holdings-for-up-to-20-Million.html